Endocytosis is a regulated physiological process by which cell surface proteins are internalized along with extracellular factors such as nutrients, pathogens, peptides, toxins, etc. The process begins with the invagination of small regions of the plasma membrane which ultimately form intracellullar vesicles. These internalized vesicles may shuttle back to the plasma membrane to recycle the membrane components or they may be targeted for degradation. One role for endocytosis is in the attenuation of receptor signaling. For example, desensitization of activated membrane bound receptors such as G-protein coupled receptors (GPCRs) or receptor tyrosine kinases (RTKs) occurs, in part, through endocytosis of the activated receptor. However, accumulating evidence suggests that endocytosis also mediates intracellular signaling. In this review, we discuss the experimental data that implicate endocytosis as a critical component in cellular signal transduction, both in the initiation of a signal as well as in the termination of a signal. Furthermore, we focus our attention on a recently described adaptor protein, intersectin (ITSN), which provides a link to both the endocytic and the mitogenic machinery of a cell. Thus, ITSN functions at a crossroad in the biochemical regulation of cell function. Oncogene (2001) 20, 6300 ± 6308.
Keywords: Eps15 homology; Src homology 3; GTPase; ubiquitination Clathrin-dependent endocytosis begins with the assembly of clathrin-coated pits (CCPs) which are composed of the basic building blocks of clathrin and the adaptor-binding protein 2 complex (AP2). Since a number of recent reviews describe endocytosis in detail we will only brie¯y review this process (Ceresa and Schmid, 2000; Marsh and McMahon, 1999; Slepnev and De Camilli, 2000; Waterman and Yarden, 2001) . Once recruited to the plasma membrane, clathrin forms the characteristic lattice network composed of the three-legged triskelia. These triskelia, which form through the combination of three heavy and three light chains of clathrin, assemble into stable oligomeric complexes that induce curvature in the plasma membrane thereby leading to the formation of CCPs. In the presence of accessory factors, the CCPs progress to form clathrin coated vesicles (CCVs), a step that requires the GTPase activity of dynamin to promote the ®ssion of membranes thereby releasing the CCVs. The resulting CCVs then undergo a process of uncoating in which clathrin is removed from the vesicles. The uncoated vesicles are then targeted for several possible fates including fusion with the endosomal compartment followed by degradation or recycling back to the cell surface.
A wealth of experimental data suggests that one role for endocytosis is the downregulation of surface membrane proteins. However, an emerging theme in signal transduction is that endocytosis is an integral component in the successful activation of speci®c signaling pathways, in particular the Erk1/2 MAPK pathway. To assess the role of endocytosis in receptor signaling, dominant interfering mutants of dynamin have been utilized which no longer bind or hydrolyze GTP and thereby inhibit endocytosis Daaka et al., 1998; Damke et al., 1994; DeGra et al., 1999; Della Rocca et al., 1999; Ignatova et al., 1999; Johannessen et al., 2000; Kao et al., 1998; Kranenburg et al., 1999; Li et al., 1999; Lin et al., 1998 Lin et al., , 1999 Pierce et al., 2000; Schramm and Limbird, 1999; Vieira et al., 1996; Whistler and von Zastrow, 1999; Yang et al., 1999; Zhang et al., 2000) . These studies indicate that although a number of receptors require endocytosis for ecient activation of the MAPK pathway Daaka et al., 1998; Della Rocca et al., 1999; Ignatova et al., 1999; Lin et al., 1998 Lin et al., , 1999 Whistler and von Zastrow, 1999) , still others do not (DeGra et al., 1999; Li et al., 1999; Schramm and Limbird, 1999; Yang et al., 1999) . In the case of GPCRs, this apparent discrepancy may be explained in part by dierent mechanisms of action of the various receptors. Although some GPCRs do not undergo endocytosis yet still activate MAPK, e.g. a 2A -adrenergic receptor, there still appears to be a requirement for endocytosis of an intermediate protein, e.g. trans-activated RTKs, in order to obtain ecient MAPK activation (Pierce et al., 2000) . Thus, the dierences mentioned above may represent distinct mechanisms of action between various receptors.
The above explanation, however, does not account for all the apparent discrepancies with regard to the involvement of endocytosis in MAPK activation. For example, some groups have demonstrated a requirement for endocytosis of the activated epidermal growth factor receptor (EGFR) for ecient coupling to MAPK activation Della Rocca et al., 1999; Kao et al., 1998; Kranenburg et al., 1999; Vieira et al., 1996) . Still others have reported no involvement of endocytosis in this pathway (DeGra et al., 1999; Johannessen et al., 2000) . Although there exists some discrepancies as to the precise role of endocytosis in MAPK activation by certain receptors, a clear role for this process in mediating activation of signaling cascades is emerging.
In addition to mutant dynamin, constitutively active forms of the small molecular weight Ras-like GTPases, Rac and Rho, also inhibit endocytosis . Although these GTPases are important regulators of membrane dynamics and the actin cytoskeleton, treatment of cells with disruptors of the actin cytoskeleton does not alter the inhibitory eects of these GTPases suggesting that their role in endocytosis is distinct from their regulation of cytoskeletal architecture and membrane dynamics . Thus, an alternative mechanism for their inhibitory eects on endocytosis may exist. A clue to this mechanism may be found in the recent identi®ca-tion of synaptojanin 2 as an eector of the Rac GTPase (Malecz et al., 2000) . Synaptojanin 2, like synaptojanin, possesses two distinct inositol polyphosphatase domains (Nemoto et al., 1997) which appear to regulate the levels of phosphoinositides important for endocytosis. The Rac-synaptojanin 2 interaction leads to the translocation of synaptojanin 2 to the plasma membrane where it exerts its inhibitory eects on endocytosis presumably through the dephosphorylation of PI(4,5)P 2 , a positive mediator of endocytosis. Indeed, a number of components of the endocytic machinery bind various forms of inositol phosphates (Corvera et al., 1999) . Although a mutant form of synaptojanin 2 that is constitutively membrane bound inhibits endocytosis, there was no eect on membrane ruing induced by EGF further supporting the notion that the role of Rac and Rho in endocytosis is distinct from their eects on the cytoskeleton. However, work in Saccharomyces cerevisiae clearly points to an important function of the actin network in regulation of endocytosis (reviewed in Munn, 2001) . By comparison, the importance of the actin cytoskeleton for endocytosis in mammalian cells appears to be more varied (Fujimoto et al., 2000) .
Endocytosis also aords the cell the opportunity to compartmentalize signaling events. Thus, certain eectors may interact with an activated receptor at the cell surface while others interact at distinct compartments within the cell. Signaling by the EGFR provides one example of this phenomenon. The interaction of the activated EGFR with phospholipase C appears to be spatially restricted to receptors at the plasma membrane (Emlet et al., 1997; Haugh et al., 1999b) whereas p21/CIP is preferentially activated by internalized EGFR (Skarpen et al., 1998) . This phenomenon is also nicely illustrated by the high anity nerve growth factor receptor, TrkA. Activation of cell surface TrkA leads to pro-survival signals, whereas internalized TrkA receptors activate a dierentiation signal (Zhang et al., 2000) . Thus, signaling speci®city may be achieved, in part, by where an activated receptor is spatially localized.
Recent studies from Drosophila suggest that endocytosis may not only function in the transduction of signals from receptors but may also play a central role in the activation of receptors (Parks et al., 2000) . Notch is a transmembrane receptor that regulates neuronal cell fate in the Drosophila embryo (Kadesch, 2000) . Notch binds to transmembrane ligands known as DSL proteins (Delta, Serrate and Lag-2) and then undergoes a series of proteolytic cleavages resulting in the release of both a soluble intracellular domain (ICD) fragment and a soluble extracellular domain (ECD) fragment. The soluble ICD migrates to the nucleus where it regulates transcription of target genes (Kadesch, 2000) . Using genetic mutants in endocytosis, Parks and colleagues demonstrated a requirement for endocytosis of Delta and the Notch ECD into Deltaexpressing cells for ecient release of the Notch ICD and subsequent Notch signaling, a process termed trans-endocytosis' (Parks et al., 2000) . Thus, endocytosis both regulates activation of receptors as well mediates signaling from activated receptors.
An involvement of endocytic proteins in the transformation process further supports the link between endocytosis and cellular signaling (Floyd and De Camilli, 1998 ). An amphiphysin-like protein, Alp-1, was isolated as a c-Abl binding protein (Kadlec and Pendergast, 1997) . Alp-1 is 95% identical to a novel human Myc-interacting protein, Bin-1, and appears to be a splice variant of Bin-1 although ALP-1 does not bind Myc. Expression of Alp-1 induces morphological transformation of cells in a c-Abl-dependent manner suggesting a role for Alp-1 in cellular growth control (Kadlec and Pendergast, 1997) . In contrast, expression of Bin-1 appears to antagonize Myc function suggesting that this splice variant of Alp-1 may be a tumor suppressor (Elliott et al., 1999; Sakamuro et al., 1996) . Interestingly, amphiphysin has also been linked to certain human cancers (reviewed in Floyd and De Camilli, 1998) .
Perhaps the most striking evidence for the involvement of endocytosis in oncogenesis is the identi®cation of three genes encoding endocytic proteins as the targets of chromosomal translocations in several human leukemias (reviewed in Floyd and De Camilli, 1998) . The gene encoding Eps15 was found as a fusion partner with the ALL1/HRX gene [t(1;11)(p32;q23)] (Bernard et al., 1994) . Similarly, the gene encoding endophilin, or EEN, was also found as a fusion with ALL1/HRX [t(11;19)(q23;p13)] (So et al., 1997) . Finally, the CALM gene is the target of a translocation with the AF-10 gene in a human lymphoma cell line [t(10;11)(p13;q14)] (Dreyling et al., 1996) . Each of these translocations results in the production of a fusion protein containing an important domain for endocytosis (Eps15 homology (EH) domain of Eps15, Src homology 3 (SH3) domain of endophilin, espin Nterminal homology (ENTH) domain of CALM). Thus, these ®ndings suggest that dysregulation of endocytic proteins may have dramatic consequences to the cell in terms of growth regulation and tumorigenesis.
The above experimental data provide compelling evidence for an intimate linkage between signal transduction pathways and the endocytic machinery. However, what is the molecular link between the endocytic machinery and the mitogenic machinery? The recent identi®cation of the protein intersectin (ITSN) provides one possible answer to this question.
ITSN is a multifunctional adaptor protein
ITSN (also known as Ese-1, EHSH-1, Dap-160) has been isolated by a number of groups based on its ability to bind proline-rich peptides (ITSN) (Yamabhai et al., 1998) , to form a complex with dynamin (Dap-160) (Roos and Kelly, 1998) and SNAP-23/25 (EHSH-1) (Okamoto et al., 1999) , its homology to SH3-containing proteins (Ese-1) (Sengar et al., 1999) and its localization to human chromosome 21 (ITSN) (Guipponi et al., 1998b) . ITSN is a 145 kDa adaptor protein consisting of two amino-terminal Eps15 homology domains (EH), a central coiled-coil domain (CC) and ®ve tandem Src homology 3 domains (SH3) (Figure 1) . EH domains promote the interaction with Asp-Pro-Phe sequences and are present in numerous endocytic accessory proteins (Santolini et al., 1999) . CC domains promote both homo-and heterotypic interactions with other CC-containing proteins and are also widely distributed (Lupas, 1996) . SH3 domains recognize Pro-rich sequences within target proteins and are present in a variety of cytoskeletal and signaling proteins (Mayer and Eck, 1995) .
ITSN is conserved throughout evolution with homologues present in humans, rodents, Xenopus, Drosophila and likely C. elegans (Figure 1 ). ITSN proteins are present predominantly in the nervous system with lower expression elsewhere (Guipponi et al., 1998b; Okamoto et al., 1999; Sengar et al., 1999) . In addition, there is a larger (*200 kDa) isoform of ITSN, termed intersectin-long (ITSN-L), that is predominantly expressed in the nervous system (Hussain et al., 1999) although lower levels of ITSN-L are present in additional tissues by Western blot analysis (O'Bryan et al. unpublished observations). This isoform is derived by alternative RNA splicing (Guipponi et al., 1998a) . ITSN-L possesses a carboxy-terminal extension encoding a Dbl homology domain (DH), a H-ITSN-1/2 are human; Ese-1/2 are mouse; EHSH-1 is rat; X-ITSN is Xenopus; Dap-160 is Drosphila; and y116a8c.36 is a predicted protein from the C. elegans genome data base. The presence of a longer splice variant encoding a RhoGEF is indicated by the presence of a DH/PH/C2 region to the right of the short form. The ??? above the EHSH1 DH/PH/C2 region indicate that this isoform has not yet been isolated but is predicted to exist based on homologies between mouse and rat. Additionally, searches of the Drosophila and C. elegans genomes data bases suggest that there is not a larger splice variant in these species. On the right, is indicated the per cent amino acid sequence identity of the short forms of ITSN in comparison to human ITSN. Dap-160 consists of two splice variants which dier in a short stretch of amino acids between SH3b and SH3c. The remainder of the proteins are identical to one another pleckstrin homology domain (PH) and a C2 domain. DH domains function as guanine nucleotide exchange factors (GEFs) for the Rho subfamily of Ras-like GTPases which include Rho, Rac and Cdc42 (Whitehead et al., 1997) . These domains function in concert with PH domains which direct interaction with lipids and membrane (Hurley and Misra, 2000) . Thus, ITSN-L may serve to regulate Rho family activation within the nervous system. C2 domains bind phospholipid membranes, proteins or soluble inositol polyphosphates using both Ca 2+ -dependent and -independent mechanisms (Hurley and Misra, 2000) . Interestingly, EH domains also bind Ca 2+ although an importance for this activity in the function of this domain has not been demonstrated (de Beer et al., 1998 ). An ITSNrelated protein, termed ITSN-2/Ese-2, has also been identi®ed (Pucharcos et al., 2000; Sengar et al., 1999) . ITSN-2 shares a similar structural architecture with ITSN-1 possessing both long and short isoforms (Figure 1) . In contrast to ITSN-1L, ITSN-2L appears to be more widely expressed suggesting that this isoform is a more general regulator of Rho family members. For the remainder of this review we will refer to ITSN-1 as ITSN.
The domain structure of ITSN suggests that this protein may act as a scaolding or adaptor protein that regulates various biochemical pathways. ITSN localizes to CCPs via the EH region suggesting that it may serve to assemble multiprotein complexes at sites of CCP formation. Indeed, ITSN associates directly with a number of proteins including epsin Yamabhai et al., 1998) , secretory carrier membrane protein 1 (SCAMP1) (Fernandez-Chacon et al., 2000) , HIV Rev binding protein (Yamabhai et al., 1998) , Eps15 (Sengar et al., 1999) , SNAP-23/25 (Okamoto et al., 1999) , dynamin; (Okamoto et al., 1999; Roos and Kelly, 1998; Sengar et al., 1999; Yamabhai et al., 1998) , synaptojanin (Yamabhai et al., 1998) and a Ras GEF, Sos (Tong et al., 2000b) (Figure 2 ). Given the number of distinct protein:protein interaction domains present in ITSN as well as the propensity of these domains to interact with numerous partners, it is highly likely that additional interacting proteins remain to be identi®ed.
Several lines of evidence suggest that ITSN does indeed regulate cellular signaling pathways. Firstly, ITSN, through its SH3 domains, forms a stable complex with Sos both in vitro and in vivo (Tong et al., 2000b) . Secondly, ITSN directly activates mitogenic signaling pathways (Adams et al., 2000) . Thirdly, overexpression of ITSN is sucient to induce morphological transformation of rodent ®broblast as well as accelerate hormone-induced Xenopus oocyte maturation in culture (Adams et al., 2000) . Finally, as mentioned earlier, ITSN-L possesses an exchange factor domain for the Rho family of GTPases suggesting that ITSN may regulate Rho, Rac or Cdc42 as well as Ras (see Figure 4) (Adams et al., 2000; Pucharcos et al., 2000; Sengar et al., 1999; Yamabhai et al., 1998) . Together these data provide compelling evidence that ITSN directly participates in cellular signaling. These ®ndings are discussed in more detail in the following sections.
ITSN complexes with the Ras guanine nucleotide exchange factor Sos
Binding of ligand to a RTK stimulates the intrinsic tyrosine kinase activity of the receptor leading to the autophosphorylation of sites within the cytoplasmic domain. These autophosphorylation sites serve as binding sites for Src homology 2 (SH2) and phosphotyrosine binding (PTB) domain-containing proteins (Pawson and Scott, 1997) . One such protein is Grb2 which is believed to exist in a complex with Sos. Thus, Figure 2 ITSN (Adams et al., 2000; Tong et al., 2000a) . Furthermore, overexpression of full-length ITSN is sucient for activation of Ras in the absence of added growth factors or serum (O'Bryan, manuscript in preparation). These ®ndings suggest that ITSN does indeed function in the regulation of Ras activation. More interestingly, these ®ndings suggest that ITSN may speci®cally target Ras activation to sites of endocytosis. Indeed, Ras is activated on endocytic vesicles (Haugh et al., 1999a) .
Although ITSN may provide one means through which Ras is activated at the endosome, others have found that whole animal administration of EGF leads to the relocalization of Shc, Grb2 and Sos to the endosome (Di Guglielmo et al., 1994) . The authors suggest that this relocalization may provide a means by which compartmentalized signaling is accomplished within the cell. However, in the case of Ras activation, it is not clear whether there is a greater contribution of Grb2 or ITSN toward activation of Ras at the endosome. Additionally, the interaction of Sos with Grb2 versus ITSN may dierentially aect the activity of the associated Rac GEF domain present in Sos. Indeed, precedent exists for modulation of the Rac GEF activity of Sos by distinct protein complexes (Scita et al., 1999) .
ITSN stimulates mitogenic signaling pathways
Recent results indicate that ITSN is able to directly activate mitogenic signaling pathways (Adams et al., 2000) . Expression of either full-length ITSN or the isolated EH region is sucient to stimulate activation of the transcription factor Elk-1. This activity appears to be independent of the classical MEK-Erk pathway suggesting that ITSN may activate an alternative MAPK pathway. Interestingly, in some cell types Elk-1 is activated by non-MEK-Erk pathways (Whitmarsh et al., 1997) . Since expression of ITSN inhibits endocytosis, one possible explanation for ITSN's signaling activity may be an indirect eect (Pucharcos et al., 2000; Sengar et al., 1999; Simpson et al., 1999) . That is, ITSN may inhibit endocytosis of membrane bound receptors, such as the EGFR, thereby leading to sustained signaling from these receptors and hence increased Elk-1 activation. This explanation, however, predicts that ITSN activation of Elk-1 would be sensitive to inhibition of these receptors. Interestingly, activation of Elk-1 by ITSN is not aected by inhibition of the EGFR by PD153035, an EGFRspeci®c inhibitor (Fry, 1999; O'Bryan, unpublished observations) . Thus, ITSN's eects on signaling appear to be independent of its eects on endocytosis at least with respect to Elk-1 activation.
Although expression of the EH region of ITSN is sucient for activation of transcription, expression of epsin, an EH binding protein, does not recapitulate this activity (Adams et al., 2000) . These ®ndings suggest that either epsin does not participate in the activation of Elk-1 or that additional components are involved. However, the possibility that epsin functions in the regulation of transcriptional events is suggested by the ®nding that epsin binds the transcription factor promyelocytic leukemia Zn 2+ ®nger protein (PLZF) . Furthermore, epsin appears to shuttle between the nucleus and cytoplasm as demonstrated by treatment of cells with Leptomycin B . Thus, the role of epsin in signaling warrants further investigation.
A role for dynamin-2 in regulating apoptotic signaling pathways has been recently described (Fish et al., 2000) . Expression of a mutant form of dynamin-2 (analogous to the mutant form of dynamin mentioned earlier) induces apoptosis through a p53-dependent response that depends on the transcriptional activity of p53. As with ITSN, the signaling eects of dynamin 2 are independent of any eects on endocytosis (Fish et al., 2000) . Thus, at least two endocytic proteins are able to regulate transcriptional events.
ITSN cooperates with the EGFR to regulate cellular signaling ITSN cooperates with the EGFR to synergistically enhance transcriptional activation and transformation (Adams et al., 2000) . The mechanism for this cooperativity is currently unknown but does appear to involve the MAPK pathway even though ITSN itself does not activate MAPK (Adams et al., 2000) . Given that ITSN may complex with a myriad of cellular substrates through each of its modular domains (Figure 2) , there may be substrates that allow for cross-talk with RTKs. As mentioned above, ITSN appears to regulate Ras activation, at least in part, through interaction with Sos. Thus, the cooperativity between ITSN and EGFR may stem from an enhanced activation of the Ras pathway. This idea is supported by the ®nding that inhibition of MEK abolishes the synergistic activation of Elk-1 by ITSN and EGF (Adams et al., 2000) .
A link between ITSN and RTK signaling can be inferred from the results of genetic experiments in Drosophila photoreceptor cell development (Cadavid et al., 2000) . Mutations in the gene encoding the Drosophila homolog of epsin, Liquid facets (Lqf), lead to defects in photoreceptor development (Cadavid et al., 2000) , a process controlled in part by the Sevenless (Sev) RTK (Rubin, 1991) . Mutations in the gene encoding Fat facets (Faf), a deubiquitinating enzyme, enhance R7 photoreceptor development (Fischer-Vize et al., 1992; Huang et al., 1995) . Loss of Lqf function enhances the Faf mutant phenotype suggesting that these two proteins function in the same pathway. Furthermore, both the Faf and Lqf mutants are sensitive to mutations in the ubiquitination (Ub) pathway as well as the endocytic pathway (Cadavid et al., 2000) . Together, these genetic and biochemical data suggest that Faf is required for the deubiquitination and activation of Lqf which then inhibits Sev signaling, presumably through clathrin-dependent downregulation of the receptor (Figure 3) . Loss of Faf function might therefore lead to increased ubiquitination of Lqf thereby targeting the protein for degradation through the ubiquitin-proteasome pathway. Interestingly, faf mutations are suppressed by an extra copy of lqf suggesting that ubiquitination of Lqf is a tightly controlled, rate limiting step that can be overcome through increased expression of Lqf (Cadavid et al., 2000) . Given the interaction between ITSN and epsin (Yamabhai et al., 1998) , these data along with our results support the idea that ITSN regulates RTK signaling. Conversely, the interaction of ITSN with epsin suggests that Dap-160 (the Drosophila ITSN homolog) may also be involved in photoreceptor development. Finally, these results further suggest that ITSN may be linked to the ubiquitination pathway. This notion is supported by the ®nding that Cbl, an E3-ubiquitin ligase involved in RTK regulation (see review this issue), interacts with the SH3 domains of ITSN by yeast two-hybrid analysis (Robertson et al., 1997) as well by co-immunoprecipitation and in vitro binding analysis (RP Mohney, manuscript in preparation).
ITSN functions in transformation and dierentiation
In addition to its role in activating Elk-1, ITSN is sucient to induce morphological transformation of rodent ®broblast as well as accelerate hormone-induced Xenopus oocyte maturation (Adams et al., 2000) . Consistent with this ®nding Eps15 also induces oncogenic transformation of cells in culture (Fazioli et al., 1993) . Furthermore, Eps15 is a substrate of the EGFR that functions in the downregulation of the (Huang et al., 1995) which is thought to activate Lqf, a homolog of mammalian epsins (Chen et al., 1998) . Given the role of epsins in regulating endocytosis, Lqf is thought to regulate endocytosis of the Sev thereby inhibiting its function (Cadavid et al., 2000) . Mutations in dynamin, adaptin and clathrin heavy chain were shown to enhance the Faf and Lqf phenotypes further supporting a role for endocytosis in this process. Additionally, mutations in the Ub machinery (UbcD1 encodes an ubiquitin conjugating enzyme; l(3)73Ai encodes a proteosome subunit) appear to suppress the Lqf and Faf phenotype further supporting a role for these proteins in the ubiquitination pathway activated EGFR through regulation of endocytosis of the receptor (Carbone et al., 1997; Fazioli et al., 1993) . ITSN and Eps15 form heterodimers in vivo (Sengar et al., 1999) . Thus, ITSN and Eps15 may act coordinately to regulate both signaling and downregulation of activated RTKs. These ®ndings further support the premise that ITSN as well as other EH family proteins may function both in the regulation of endocytosis as well as cellular growth control.
ITSN may coordinately regulate GTPase cascades
Rho proteins, like Ras, cycle between an active, GTPbound form and an inactive, GDP-bound form through the concerted action of GEFs and GAPs (GTPase activating proteins), respectively (Van Aelst and D'Souza-Schorey, 1997 (Figure 4) . In addition to a Ras GEF domain, Sos also possesses a DH/PH domain involved in Rac activation (Nimnual et al., 1998) . Thus, the complex of ITSN-L with Sos would result in the coalescence of three distinct GEF domains at one site. Additionally, ITSN binds to CdGAP, a novel Rac1 and Cdc42 GAP, through its SH3 domains and inhibits its GAP activity in vitro (N Lamarche-Vane, personal communication) suggesting an additional level of regulation of Rho GTPase by ITSN. Thus, ITSN and ITSN-L may assemble a multiprotein complex that coordinately regulates the activation of an important GTPase cascade, particularly at sites of coated pit formation. Indeed, Rac and Rho have been implicated in coated pit formation further supporting this notion .
Although the inhibition of MAPK by the SH3 domains of ITSN is certainly due in part to inhibition of Ras (Tong et al., 2000a,b) , it is also possible that the decrease in MAPK activation may be due in part to the inhibitory eect of ITSN on endocytosis. Overexpression of either the SH3 domains or full length ITSN is sucient to block clathrin-dependent endocytosis (Pucharcos et al., 2000; Sengar et al., 1999; Simpson et al., 1999; Tong et al., 2000a) . The inhibition of EGFR endocytosis leads to a decrease in EGF-induced MAPK activation (Vieira et al., 1996) apparently due to an inability of activated MEK to stimulate MAPK (Kranenburg et al., 1999) . Thus, ITSN may regulate MEK activation of MAPK in addition to regulating Sos activation of Ras.
Future directions
It is becoming clear that signal transduction is intimately intertwined with endocytosis. These two processes appear to regulate one another in both a positive and negative manner. We have discussed the emerging role of the adaptor protein ITSN in bridging these two biochemical processes. The immediate task will be to precisely de®ne the mechanism by which ITSN regulates these processes. In addition, it will be important to de®ne the signals that regulate ITSN Figure 4 ITSN coordination of the Ras GTPase cascade. ITSN and ITSN-L (shown) both interact with Sos through the SH3 domains. As a result, two GEF domains speci®c for Ras family GTPases are recruited into an ITSN complex. The presence of an additional GEF in the ITSN-L suggests that this larger isoform may be able to coordinate regulation of three distinct GTPases. Furthermore, the ability of ITSN SH3s to bind and inactivate a Rac GAP (not shown), suggest that ITSN may also regulate Rac activation (Lamarche-Vane, personal communication). Although ITSN is thought to function in part to regulate Ras GTP levels (Tong et al., 2000b ; O'Bryan, manuscript in preparation), experimental proof for coordinate regulation of a GTPases cascade awaits function. Is the association of ITSN with CCPs regulated or constitutive? Does ITSN undergo posttranslational modi®cation following receptor activation, e.g. phosphorylation or ubiquitination, as seen with Eps15 (Fazioli et al., 1993; vanDelft et al., 1997) ?
Given the role of ITSN in signaling and endocytosis, is ITSN involved in human disease? Several lines of evidences suggest that the answer to this question is yes. For example, the localization of ITSN to human chromosome 21 in the Down Syndrome (DS) region and the elevated expression of ITSN mRNA in brains of DS patients suggest a potential role for this protein in the etiology of DS (Guipponi et al., 1998a; Pucharcos et al., 1999) . Increased expression of ITSN in cells of DS patients may lead to improper signaling thereby altering neural development or function. In addition, increased levels of ITSN may interfere with receptor-mediated endocytosis leading to dysregulated signaling. Moreover, the eects of ITSN on endocytosis may contribute to the altered processing of amyloid precursor protein and the generation of the amyloidogenic form of Ab peptide associated with both DS and Alzheimer's disease (AD). Such a role for endocytosis in AD and DS has been suggested previously (Haass et al., 1992) and is supported by pathological ®ndings from brains of both DS and AD patients (Cataldo et al., 2000) .
The ability of ITSN to transform cells, together with the fact that several endocytic proteins have been found as chromosomal translocations in human malignancies as described earlier, suggests that ITSN, like Eps15, endophilin and CALM, may also be involved human carcinogenesis. The stimulation of mitogenic signaling pathways by ITSN supports this possibility, although no direct evidence has yet been uncovered.
Continued research into the function of ITSN as well as other endocytic accessory factors and signaling proteins will likely reveal additional connections between the processes of endocytosis and cellular signaling. These studies, in turn, will expand our understanding of the biochemical mechanism behind these two distinct yet inter-related processes. Furthermore, future studies will likely reveal important mechanisms by which normal and disease processes are regulated.
